Skip to main navigation Skip to search Skip to main content

Accelerator-driven boron neutron capture therapy

Rob Edgecock

Research output: Contribution to journalArticlepeer-review

Abstract

Boron Neutron Capture Therapy is a binary treatment for certain types of cancer. It works by loading the cancerous cells with a boron-10 carrying compound. This isotope has a large cross-section for thermal neutrons, the reaction producing a lithium nucleus and alpha particle that kill the cell in which they are produced. Recent studies of the boron carrier compound indicate that the uptake process works best in particularly aggressive cancers. Most studied is glioblastoma multiforme and a trial using a combination of BNCT and X-ray radiotherapy has shown an increase of nearly a factor of two in mean survival over the state of the art. However, the main technical problem with BNCT remains producing a sufficient flux of neutrons for a reasonable treatment duration in a hospital environment. This paper discusses this issue.

Original languageEnglish
Article number1441004
JournalInternational Journal of Modern Physics A
Volume29
Issue number14
Early online date26 May 2014
DOIs
Publication statusPublished - 10 Jun 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Accelerator-driven boron neutron capture therapy'. Together they form a unique fingerprint.

Cite this